Achal Singh Achrol MD

Achal Singh Achrol, MD, is the Director of Neurovascular Surgery and Neurosurgery Clinical Trials Program at the Pacific Neuroscience Institute and Chief of the Glioma Surgery Program at the John Wayne Cancer Institute at Providence Saint John’s Health Center. 

Dr. Achrol specializes in computer-assisted minimally invasive keyhole and microvascular neurosurgery, using advanced neuroimaging and stereotactic navigation techniques to safely reach even the most difficult lesions. As an academic neurosurgeon and physician scientist, Dr. Achrol is committed to leading translational research programs that advance treatment options for patients suffering from brain tumors, stroke, intracranial aneurysms and vascular malformations. 

As the Director of Neurovascular Surgery, Dr. Achrol works closely with specialists in stroke neurology, interventional neuroradiology and neurocritical care to offer a team-based approach to the personalized, comprehensive care of patients with stroke, brain aneurysms and vascular malformations. The neurovascular program offers minimally invasive endovascular treatments, keyhole/microvascular neurosurgery and non-invasive adjuvant therapies. 

As Chief of the Glioma Surgery Program, Dr. Achrol leads a translational research team committed to improving the quality of life and overall outcomes for patients through state-of-the-art treatments and advanced clinical trials. Dr. Achrol evaluates patients using a team-based approach that includes specialists in neurology, oncology, genetics, radiation oncology, head and neck surgery (ENT) and neuro-radiology. This broad expertise allows the Glioma Surgery Program to offer patient’s the most advanced personalized medicine treatments and precision therapy clinical trials, including immunotherapy (check point inhibitors, cancer vaccines, oncolytic virus therapy), stem cell therapies and genome-guided targeted molecular therapies.